Patients with moderate‑to‑severe plaque psoriasis achieve greater relief from itching, skin pain, and scaling with bimekizumab vs secukinumab up to 3 years.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/bimekizumab-eases-plaque-psoriasis-symptoms-3-years-2026a100052j?src=rss
Author :
Publish date : 2026-02-18 16:05:00
Copyright for syndicated content belongs to the linked Source.
